Articles

With meme stocks in a lull, here’s where retail investors may turn their attention next

The dynamics that fueled the meme-stock frenzy have not gone away, according to a new study.

FTC sues prescription-drug middlemen over insulin prices, says drugmakers are also ‘on notice’

Pharmacy-benefit managers owned by CVS, Cigna and UnitedHealth “artificially inflated” prices for lifesaving medications, regulator alleges.

Social Security’s COLA provides invaluable protection

Recent inflation spike — and moderation — underscores its importance

Why Fed bets were so out of whack: Waller explains what put him ‘over the edge’ for a jumbo rate cut

Inflation might actually fall too far, Fed governor says.

Why Constellation Energy and Vistra shares are building on massive gains

Constellation has a new nuclear-power deal with Microsoft. Both Constellation and Vistra shares have more than doubled this year on optimism for data-center power deals.

Small-cap stocks post longest rally since 2021 after Fed rate cut. What’s next?

Small-cap stocks just saw their longest winning streak in three and a half years, after the Federal Reserve recalibrated its monetary policy with a big interest-rate cut. 

‘Powell delivered the stock market to the Promised Land.’ Why the S&P 500 could soar past 6,000 by year-end.

Yardeni: Odds of a 1990s-like market boom have increased after Fed rate-cut.

Trump Media & Technology Group’s stock hits low as insider stock-sale ban lifts

Trump Media & Technology Group Corp.’s stock dropped to its lowest level since it went public in March Friday, as a ban on stock sales lifted.

Four things you need to know about Medicare drug costs and coverage in 2025 

With Medicare prescription-drug benefits on the brink of a shake-up, enrollees who hope to minimize their costs at the pharmacy counter next year need to stay vigilant in the coming months. 

Traders face biggest index rebalancing in four years on Friday: Here’s what to watch for

Investors are facing the busiest quarterly rebalancing in about four years on Friday in a shakeup that could impact roughly $250 billion worth of stocks, according to a team of equity analysts at Piper Sandler.

Electric vehicles are suddenly the best deal in the used-car market

The average monthly payment on used electric vehicles, which are now cheaper than hybrids and gas-engine cars, are approaching affordable levels for middle-income households.

Nike’s stock has been dogged by these issues. Can a new CEO change the game?

New Nike CEO Elliot Hill is inheriting “a turnaround that has yet to show momentum,” according to Stifel analyst Jim Duffy.
1 989 990 991 992 993 2,544